Has Heather Thomassie received payments from drug or device companies?

Yes. Drug and device makers reported $1,768 in general payments to Heather Thomassie across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heather Thomassie did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heather Thomassie come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heather Thomassie

Family · Thibodaux, LANPI 1548613136

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 100 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$172
AbbVie$166
Novo Nordisk$128
Amgen$87
Merck$79
Boehringer Ingelheim$79
plus $1K from 29 others

What the payments were for

Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	10	$172
AbbVie	9	$166
Novo Nordisk	8	$128
Amgen	5	$87
Merck	5	$79
Boehringer Ingelheim	5	$79
Corium, LLC	3	$74
Johnson & Johnson	4	$71
Exact Sciences	3	$69
Novartis	4	$60
Ironshore Pharmaceuticals Inc.	3	$56
Dexcom, Inc.	2	$54
Sumitomo Pharma America, Inc.	3	$49
Abbott	3	$49
Bayer	3	$48
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$48
Pfizer	2	$46
AstraZeneca	3	$45
Adlon Therapeutics L.p.	2	$39
Cranial Technologies, Inc	2	$39
Esperion Therapeutics, Inc.	2	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$35
GSK	2	$34
Axsome Therapeutics, Inc.	1	$22
Phathom Pharmaceuticals, Inc.	1	$20
Sanofi Pasteur Inc.	1	$19
Aimmune Therapeutics, Inc.	1	$19
Seqirus USA Inc	1	$18
Amarin Pharma, Inc.	1	$17
Clarus Therapeutics Inc.	1	$16
Eisai Inc.	1	$16
Astellas Pharma US Inc	1	$16
Otsuka America Pharmaceutical, Inc.	1	$15
Shield Therapeutics Inc	1	$15
Biohaven Pharmaceutical Holding Company Ltd.	1	$14

How this compares

$1,768 in reported general payments places this provider in the 70th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate	20	$456
Albuterol Sulfate HfaAlbuterol Sulfate	11	$438
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	40	$383
Pantoprazole Sodium	33	$271
Azithromycin	54	$265
Doxycycline Hyclate	44	$198
Levothyroxine Sodium	22	$180
Alprazolam	69	$177
Ciprofloxacin Hcl	38	$175
Metoprolol Succinate	19	$173
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	32	$172
Zolpidem Tartrate	35	$151
Escitalopram Oxalate	14	$116
Citalopram HbrCitalopram Hydrobromide	43	$115
Mupirocin	16	$98

Paid to pharmacies, not to this prescriber.

Other family in Thibodaux

Rebecca EzellSlidell$268K
Erin PierceNew Orleans$261K
Tavell KindallNew Orleans$194K
Ashlea HillRuston$169K
Brittany MillerVille Platte$158K
Ryanne ClarkeGretna$123K
Elidia DewittBaton Rouge$108K
Rebekah GarrardLafayette$105K
Tiffany RoeShreveport$97K
Ghenet GhebretatiosBaton Rouge$91K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →